A Model of Medical Countermeasures for Vesicant Exposure
Abstract
This paper describes a toxicokinetic/dynamic model of percutaneous exposure to several vesicants. The model also predicts the efficacy of proposed medical countermeasures via a pharmacokinetic/dynamic model of scavenger, cell-cycle inhibitor, PARP inhibitor, protease inhibitor, and anti-inflammatory treatment regimens.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2015
- Accession Number
- ADA623488
Entities
People
- Gene E. Mcclellan
- Glen I. Reeves
- Jason Rodriguez
Organizations
- Applied Research Associates (United States)